|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1995-9-8
|
|
pubmed:abstractText |
To assess the prognostic value of the pretreatment potential doubling time (Tpot) in carcinoma of the uterine cervix, relative to other established clinical factors.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1319-29
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7635771-Adenocarcinoma,
pubmed-meshheading:7635771-Adult,
pubmed-meshheading:7635771-Aged,
pubmed-meshheading:7635771-Biopsy,
pubmed-meshheading:7635771-Brachytherapy,
pubmed-meshheading:7635771-Bromodeoxyuridine,
pubmed-meshheading:7635771-Carcinoma, Squamous Cell,
pubmed-meshheading:7635771-Cell Cycle,
pubmed-meshheading:7635771-Confidence Intervals,
pubmed-meshheading:7635771-DNA, Neoplasm,
pubmed-meshheading:7635771-Disease-Free Survival,
pubmed-meshheading:7635771-Female,
pubmed-meshheading:7635771-Flow Cytometry,
pubmed-meshheading:7635771-Follow-Up Studies,
pubmed-meshheading:7635771-Humans,
pubmed-meshheading:7635771-Kinetics,
pubmed-meshheading:7635771-Middle Aged,
pubmed-meshheading:7635771-Mitotic Index,
pubmed-meshheading:7635771-Neoplasm Staging,
pubmed-meshheading:7635771-Prospective Studies,
pubmed-meshheading:7635771-Quality Assurance, Health Care,
pubmed-meshheading:7635771-Radiotherapy,
pubmed-meshheading:7635771-Radiotherapy Dosage,
pubmed-meshheading:7635771-Regression Analysis,
pubmed-meshheading:7635771-S Phase,
pubmed-meshheading:7635771-Survival Rate,
pubmed-meshheading:7635771-Time Factors,
pubmed-meshheading:7635771-Treatment Failure,
pubmed-meshheading:7635771-Uterine Neoplasms
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Princess Margaret Hospital/Ontario Cancer Institute, University of Toronto, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
